Capacity Expansions, New Technologies, and Quarterly Results - Research Report on Thermo Fisher, Life Technologies, Agilent, PAREXEL, and PerkinElmer

NEW YORK, August 12, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Thermo Fisher Scientific, Inc. (NYSE: TMO), Life Technologies Corporation (NASDAQ: LIFE), Agilent Technologies Inc. (NYSE: A), PAREXEL International Corporation (NASDAQ: PRXL), and PerkinElmer Inc. (NYSE: PKI). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Thermo Fisher Scientific, Inc. Research Report

On August 1, 2013, Thermo Fisher Scientific Inc. (Thermo Fisher) announced the expansion of its global cell culture and bioprocessing capabilities through a new manufacturing plant in Tuas, Singapore. According to the Company, the facility will be the first-ever cell culture dry powder media (DPM) production site in Singapore, which is designed to address the increased global requirements from biopharmaceutical companies to mitigate critical raw material supply risks. "Asia continues to be our fastest-growing market and a central contributor to our growth," said Greg Herrema, President of Biosciences at Thermo Fisher Scientific. "Our new Singapore facility further strengthens our global presence, expands our manufacturing infrastructure and establishes local production capabilities to meet increased demand for biologic drug discovery and development in Asia." The Full Research Report on Thermo Fisher Scientific, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/45ed_TMO]

--

Life Technologies Corporation Research Report

On August 1, 2013, Life Technologies Corp. (Life Technologies) launched its first state-of-the-art forensics laboratory in Gurgaon, India. As per the Company, this new laboratory will provide DNA profiling services to help accelerate the sampling process, while reducing costs and saving time. "Life Technologies DNA Forensics Laboratory will reduce the burden on existing Forensic System and address the requirements of DNA database generation for un-identified dead bodies or other crime investigations," said Devashish Ohri, Managing Director of Life Technologies South Asia. "We are looking forward to partnering with the State and Central Government laboratories to assist in the establishment of a DNA database project." The Full Research Report on Life Technologies Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/d5de_LIFE]

--

Agilent Technologies Inc. Research Report

On August 1, 2013, Agilent Technologies Inc. (Agilent) announced a recent development of its Dissolution Workstation Software. According to Agilent, its new software supports laboratory capabilities to build, edit, search, retrieve, execute and archive all dissolution methods and test reports from a single interface. "One of the greatest enhancements is the addition of vibration monitoring to the Dissolution Workstation Software," said Allan Little, Marketing Director for Agilent's Dissolution Systems business. "This added benefit may be used during early research to develop internal tolerances for specific methods, or as part of a quality-control initiative for well-established methods." Agilent explained that dissolution is a technique used in the pharmaceutical industry to determine the rate at which pure active pharmaceutical ingredients dissolve. The Full Research Report on Agilent Technologies Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/075e_A]

--

PAREXEL International Corporation Research Report

On August 7, 2013, Parexel International Corp. (Parexel) reported its Q4 FY 2013 financial results (period ended June 30, 2013), posting service revenue total of $463.1 million, up 18% YoY. GAAP operating margin in Q4 FY 2013 was 8.3%, up 180 basis points compared to Q4 FY 2012. GAAP diluted EPS increased 79.3% YoY to $0.52. Commenting on the future outlook of the Company, Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer, stated, "We believe that the market for our products and services remains solid, and that PAREXEL's competitive position is favorable.  I'm excited about Fiscal Year 2014, and remain confident in our ability to generate further benefits for our shareholders." The Company anticipates its Q1 FY 2014 revenues to be in the range of $455 million to $460 million, and GAAP EPS in the range of $0.42 to $0.46. The Full Research Report on PAREXEL International Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/067b_PRXL]

--

PerkinElmer Inc. Research Report

On August 1, 2013, PerkinElmer Inc. (PerkinElmer) reported its Q2 2013 financial results with reported revenues of $543.3 million, compared to $521.8 million in Q2 2012. GAAP diluted EPS from continuing operations was $0.24 compared to $0.29 in Q2 2012. Adjusted EPS was $0.51 compared to $0.53 in Q2 2012. GAAP operating income totaled $39.7 million compared to $49.8 million in Q2 2012. "We were able to deliver sequential revenue improvements in the areas that were under pressure in the first quarter while the remaining portfolio continued to perform well," said Robert Friel, Chairman and Chief Executive Officer of PerkinElmer. "Our second quarter performance gives us confidence in our ability to deliver organic growth and improved profitability in the back half of the year." The Company anticipates full year 2013 GAAP EPS in the range of $1.40 to $1.47. The Full Research Report on PerkinElmer Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/2016_PKI]

----

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE Investors' Reports